It was part of a 3m sale of two drugs stocks by the UK's biggest quoted venture investor, as MDY snapped up 1.2% of ProStrakan at 61.5p a share, Thursday's closing price. The shares, which doubled to top 100p between March and August last year, firmed ...
Recent comments
5 years 25 weeks ago
14 years 42 weeks ago
14 years 43 weeks ago
14 years 43 weeks ago
15 years 8 weeks ago
15 years 8 weeks ago
15 years 15 weeks ago
15 years 33 weeks ago
16 years 15 weeks ago
16 years 15 weeks ago